未经批准:患有炎症性肠病(IBD)的医护人员是否因职业暴露而增加了新型冠状病毒病(COVID-19)的风险尚不清楚。
未经批准:评估IBD医护人员感染COVID-19的风险。
UNASSIGNED:一项病例对照研究招募了来自17个GETAID中心的326名IBD医护人员,并将非医护人员与IBD对照(1:1)进行性别匹配,年龄,疾病亚型和诊断年份。研究期间是COVID-19爆发期间的2020年。
未经批准:总共,病例(n=32)和对照(n=27)记录了59例COVID-19,包括2例重症COVID-19(需要住院治疗,机械通风)但没有死亡。医护人员和对照组之间在COVID-194.9±2.2和COVID-19的总发病率方面没有观察到差异。每100个患者学期3.8±1.9,P=0.34)和重症COVID-19的总体发病率(0.6±7.8vs.每100个患者学期0.3±5.5,P=0.42)。在整个研究人群的多变量分析中,COVID-19与体重指数>30kg/m2的患者相关(HR=2.48,95CI[1.13-5.44],P=0.02)。
未经授权:与其他IBD患者相比,IBD患者的医护人员患COVID-19的风险没有增加。
UNASSIGNED: Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown.
UNASSIGNED: To assess the risk of COVID-19 in healthcare workers with IBD.
UNASSIGNED: A
case control study enrolled 326 healthcare workers with IBD from 17 GETAID centres and matched non-healthcare workers with IBD controls (1:1) for gender, age, disease subtype and year of diagnosis. The study period was year 2020 during the COVID-19 outbreak.
UNASSIGNED: In total, 59 COVID-19 were recorded among cases (n = 32) and controls (n = 27), including 2 severe COVID-19 (requiring hospitalization, mechanic ventilation) but no death. No difference was observed between healthcare workers and controls regarding the overall incidence rates of COVID-19 4.9 ± 2.2 vs. 3.8 ± 1.9 per 100 patient-semesters, P = 0.34) and the overall incidence rates of severe COVID-19 (0.6 ± 7.8 vs. 0.3 ± 5.5 per 100 patient-semesters, P = 0.42). In multivariate analysis in the entire study population, COVID-19 was associated with patients with body mass index > 30 kg/m2 (HR = 2.48, 95%CI [1.13-5.44], P = 0.02).
UNASSIGNED: Healthcare workers with IBD do not have an increased risk of COVID-19 compared with other patients with IBD.